Top of the morning to you. And a fine one, it is. The sun is shining brightly over the Pharmalot corporate campus today, where we are scurrying to deposit assorted short people at assorted schoolhouses. And then, of course, we must prepare for deadlines and meetings and that sort of thing. We know you can relate. So please join us for a delicious cup of stimulation as we brace ourselves for the challenges. Meanwhile, have a great day and do stay in touch...
French Drugmakers Say State Pricing May Hamper Industry (Bloomberg News)
House Committee To Question VA Drug Purchases (Navy Times)
FDA Panel Wants Suicide Risk On Novartis ADHD Drug Label (Reuters)
Pfizer Seeks FDA OK For Long-Delayed Menopause Drug (Dow Jones)
Actelion Counts On 'Make Or Break' Lung Treatment (Bloomberg News)
Lilly Profit Falls Thanks To Zyprexa Generics (Reuters)
Pfizer Profit Buoyed By Non-Pharma Units (Bloomberg News)
Saudi Arabian Regulators Prepares Ethics Code For Pharma (Arab News)
Spain Cut Rx Spending, But Owes Pharma Billions (Pharma Times)
Watson To Open R&D HQ In New Jersey (The Star-Ledger of New Jersey)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr